ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

Unscreened Women At High Risk of Breast Cancer

October 29, 2004

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990